as 11-22-2024 4:00pm EST
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | SANTA CLARA |
Market Cap: | 289.5M | IPO Year: | 2014 |
Target Price: | N/A | AVG Volume (30 days): | 837.2K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 2.04 | EPS Growth: | -18.40 |
52 Week Low/High: | $20.88 - $76.98 | Next Earning Date: | 11-04-2024 |
Revenue: | $58,938,000 | Revenue Growth: | -11.93% |
Revenue Growth (this year): | -16.97% | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
SEMLER ERIC | SMLR | Director | Nov 7 '24 | Buy | $37.93 | 50,000 | $1,896,500.00 | 621,721 | |
Murphy-Chutorian Douglas | SMLR | CEO | Nov 7 '24 | Sell | $37.93 | 50,000 | $1,896,500.00 | 50,000 | |
Murphy-Chutorian Douglas | SMLR | CEO | Aug 28 '24 | Sell | $28.33 | 21,661 | $613,928.32 | 50,000 |
SMLR Breaking Stock News: Dive into SMLR Ticker-Specific Updates for Smart Investing
PR Newswire
5 days ago
Simply Wall St.
9 days ago
Simply Wall St.
11 days ago
Argus Research
11 days ago
Simply Wall St.
18 days ago
TipRanks
18 days ago
GuruFocus.com
18 days ago
PR Newswire
19 days ago
The information presented on this page, "SMLR Semler Scientific Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.